Rilonacept and canakinumab

被引：55
作者：
Dubois, Eline A.
Rissmann, Robert
Cohen, Adam F.
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 71卷 / 05期
关键词：
D O I：
10.1111/j.1365-2125.2011.03958.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：639 / 641
页数：3
相关论文
共 4 条
[1]   Actual status of antiinterleukin-1 therapies in rheumatic diseases [J].
Geyer, Matthias ;
Mueller-Ladner, Ulf .
CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) :246-251
[2]  
Hoffman HM, 2008, NAT REV DRUG DISCOV, V7, P385, DOI 10.1038/nrd2579
[3]   Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome [J].
Lachmann, Helen J. ;
Kone-Paut, Isabelle ;
Kuemmerle-Deschner, Jasmin B. ;
Leslie, Kieron S. ;
Hachulla, Eric ;
Quartier, Pierre ;
Gitton, Xavier ;
Widmer, Albert ;
Patel, Neha ;
Hawkins, Philip N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) :2416-2425
[4]   Rilonacept-CAPS and Beyond A Scientific Journey [J].
Stahl, Neil ;
Radin, Allen ;
Mellis, Scott .
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS, 2009, 1182 :124-134
1